Skip to main content

Fastest growing segment fueling the growth of Spinal Muscular Atrophy Market

 

Spinal Muscular Atrophy Market

The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 1813.48 Mn or Billion in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Spinal muscular atrophy is a group of inherited diseases that causes weakness and wasting in the muscles of arms, legs, neck and face due to the loss of specialized nerve cells in the spinal cord. Spinal muscular atrophy medicines help in the treatment of spinal muscular atrophy by increasing the survival rate of motor neurons and improving muscle functions.

Market key trends:

One of the key trends in the spinal muscular atrophy market is technological advancements in gene therapies. Gene therapies are novel treatment approaches that involve modifying or manipulating genes to treat or cure disease. Major companies such as Biogen and Novartis are focusing on developing advanced gene therapies for SMA through adeno-associated virus vectors. For instance, Zolgensma by Novartis is the first and only gene therapy approved by the FDA for the treatment of SMA. It uses the AAV9 vector carrying the human SMN gene to help treat the underlying cause of SMA.

Segment Analysis:

The spinal muscular atrophy market is segmented based on type, treatment, route of administration, and distribution channel. By type, the 5q SMA segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. 5q SMA accounts for approximately 95% of all SMA cases and is the most common type among SMA patients.

Key Takeaways:

The Global Spinal Muscular Atrophy Market Growth is expected to witness high, exhibiting a CAGR of 13% over the forecast period, due to increasing awareness about SMA and the availability of newer treatment options.

Regional Analysis

North America dominated the global spinal muscular atrophy market in 2022 and is expected to continue its dominance over the forecast period. The regional growth can be attributed to the rising incidence of SMA, strong presence of key pharmaceutical companies, and rapid adoption of innovative therapies in the region.

Key Players

Key players operating in the spinal muscular atrophy market are Biogen, CYTOKINETICS, F. Hoffmann-La Roche Ltd, Genentech, Inc., PTC Therapeutics, Inc., Novartis AG, Ionis Pharmaceuticals, Chugai Pharmaceutical Co., Ltd., NMD PHARMA A/S, and Astellas Pharma Inc. With the market expected to grow at a higher rate, these players are likely to invest more in R&D for innovative treatment options.

Read More - https://www.trendingwebwire.com/spinal-muscular-atrophy-market-share-and-demand-analysis/

Comments

Popular posts from this blog

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The North America Recreational Vehicle Market is Gaining Momentum by Surging Participation

North America Recreational Vehicle Market The North America recreational vehicle market offers a variety of motorhomes, campervans, caravans trailers and fifth-wheel trailers that are equipped with modern amenities for camping and recreational purposes. RVs provide comfortable spaces for cooking, sleeping and living that enable travelers to take all basic necessities while on the go. Improving standard of living and flexible work models have significantly boosted outdoor recreational activities and weekend vacations across North America. North America Recreational Vehicle Market is estimated to be valued at US$ 23.66 Bn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the North America recreational vehicle market are Thor Industries, Inc., Tiffin Motorhomes, Inc., Winnebago Industries, Inc., Forest River, Inc., Jayco, Inc., Nexus RV LLC, REV Group, Inc., Starcraft RV, Inc., Heartland Recreational Vehicles, A...

Ingaas Photodiode Sensor Market Set For Robust Growth By Growing Adoption Of Infrared Detection Applications

Ingaas Photodiode Sensor Market The InGaAs photodiode sensor market consists of photodiode sensors that are built on indium gallium arsenide (InGaAs) substrate materials. InGaAs photodiode sensors offer advantages like high sensitivity in the near-infrared wavelength range of 900 nm to 1700 nm. They are used in various infrared detection applications including optical mice, proximity sensors, IR remote controls, spectrometers, free space optics, and biometric sensors. The global InGaAs photodiode sensor market is estimated to be valued at US$ 261.71 million in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the InGaAs photodiode sensor market are First Sensor, Hamamatsu Photonics K.K., Laser Components GmbH, OSI LaserDiode, Kyoto Semiconductor Co., Ltd., Teledyne Judson Technologies (TJT), SphereOptics GmbH, and Voxtel, Inc. The growing adoption of InGaAs photodiode sensors in various infrared detection and im...